|
Volumn 20, Issue 4-7, 2001, Pages 1067-1078
|
The design and synthesis of purine inhibitors of CDK2. III
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE INHIBITOR;
CYCLIN E;
PURINE ANTAGONIST;
ANTINEOPLASTIC ACTIVITY;
BINDING AFFINITY;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CELL DIVISION;
CELL GROWTH;
CONFERENCE PAPER;
REGULATORY MECHANISM;
STRUCTURE ACTIVITY RELATION;
ADENINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CDC2-CDC28 KINASES;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASES;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
HT29 CELLS;
HUMANS;
MICE;
MICE, NUDE;
PIPERIDINES;
PROTEIN-SERINE-THREONINE KINASES;
PURINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0034840040
PISSN: 15257770
EISSN: None
Source Type: Journal
DOI: 10.1081/NCN-100002493 Document Type: Conference Paper |
Times cited : (18)
|
References (10)
|